Materialise (MTLS) investor relations material

Executive summary

• Executed strategic divestments of RapidFit and Eyewear businesses, retaining a minority stake in Eyewear and transferring all employees, to sharpen focus on core segments and capital allocation.

• Expanded medical portfolio with custom-made PEEK implants and launched OrthoView 3D Hip for advanced surgical planning and complex surgeries.

• Advanced software offerings with CO-AM Professional, onboarding first customers, and deepened partnership with HP to bundle Magics Print with the MJF 1200 printer.

• Achieved significant sustainability milestones, including publication of the first annual report post-Euronext listing, CSRD sustainability reporting, and a reduction of over 1,500 tons of CO2.

• Operational profitability improved across all segments despite geopolitical and FX headwinds.

Financial highlights

• Q1 2026 revenue was EUR 66.3 million, stable year-over-year despite FX headwinds.

• Gross profit rose to EUR 37.9 million, with gross margin expanding to 57.2% from 55.3% last year.

• Adjusted EBIT improved to EUR 2.5 million (3.7% margin), up from EUR 0.6 million.

• Net profit reached EUR 1.8 million, or EUR 0.03 per share, reversing a net loss in Q1 2025.

• Free cash flow was EUR 5.7 million, increasing net cash position to EUR 72.8 million.

Outlook and guidance

• Reaffirmed full-year 2026 revenue guidance of EUR 273–283 million and adjusted EBIT of EUR 10–12 million.

• Expects continued macroeconomic and geopolitical uncertainty but remains confident in business fundamentals and operational resilience.

• Manufacturing EBITDA expected to be positive for full year 2026.